J Gynecol Oncol.
2025 Jan;36(1):e70. 10.3802/jgo.2025.36.e70.
Clinical practice guidelines for cervical cancer: an update of the Korean Society of Gynecologic Oncology Guidelines
- Affiliations
-
- 1Department of Obstetrics and Gynecology, Daejeon St. Mary’s Hospital, The Catholic University of Korea, Daejeon, Korea
- 2Department of Obstetrics and Gynecology, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, Korea
- 3Department of Obstetrics and Gynecology, Institute of Women’s Medical Life Science, Yonsei Cancer Center, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
- 4Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam, Korea
- 5Department of Obstetrics and Gynecology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
- 6Department of Obstetrics and Gynecology, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea
- 7Department of Obstetrics and Gynecology, Keimyung University Dongsan Medical Center, Daegu, Korea
- 8Department of Obstetrics and Gynecology, CHA Ilsan Medical Center, CHA University, Goyang, Korea
- 9Department of Obstetrics and Gynecology, Hallym University Kangnam Sacred Heart Hospital, Seoul, Korea
- 10Department of Obstetrics and Gynecology, Wonju Severance Christian Hospital, Yonsei University College of Medicine, Wonju, Korea
- KMID: 2565503
- DOI: http://doi.org/10.3802/jgo.2025.36.e70
Abstract
- We describe the updated Korean Society of Gynecologic Oncology (KSGO) practice guideline for the management of cervical cancer, version 5.1. The KSGO announced the fifth version of its clinical practice guidelines for the management of cervical cancer in March 2024. The selection of the key questions and the systematic reviews were based on data available up to December 2022. Between 2023 and 2024, substantial findings from large-scale clinical trials and new advancements in cervical cancer research remarkably emerged. Therefore, based on the existing version 5.0, we updated the guidelines with newly accumulated clinical data and added 4 new key questions reflecting the latest insights in the field of cervical cancer. For each question, recommendation was formulated with corresponding level of evidence and grade of recommendation, all established through expert consensus.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Clinical practice guidelines for ovarian cancer: an update to the Korean Society of Gynecologic Oncology guidelines
- Clinical practice guidelines for cervical cancer: the Korean Society of Gynecologic Oncology guidelines
- Clinical practice guidelines for uterine corpus cancer: an update to the Korean Society of Gynecologic Oncology guidelines
- Japan Society of Gynecologic Oncology 2022 guidelines for uterine cervical neoplasm treatment
- Clinical guidelines for ovarian cancer: the Korean Society of Gynecologic Oncology guidelines
